Table 4. DHODH genotype and corresponding dose-response phenotype for representative in vitro TCMDC-125334 + DSM265 selected lines.
| Clone ID | DHODH mutation(s) | DHODH CNV | TCMDC-125334 EC50 (nM) | DSM265EC50 (nM) | IDI-6273 EC50 (nM) | Genz669178 EC50 (nM) |
|---|---|---|---|---|---|---|
| 3D7 A10 | WT | 1 | 140±42.6 | 4.5±1.6 | 502±209 | 6.9±2.2 |
| DT-F1-C1 | WT* | 2 | 260±79.5 | 8.6±1.6 | 1190±276 | 15.9±3.61* |
| DT-F1-C2 | WT† | 1 | 153±21.0 | 6.1±0.88 | 628±117 | 7.74±1.23 |
| DT-F2-C1 | V532A* | 1 | 661±145** | 79.2±19.0* | 1320±368* | 11.4±3.08 |
| DT-F2-C2 | V532A* | 1 | 536±54.4 | 82.4±23.1* | 881±185 | 8.69±2.35 |
| Overall p-value (approximate) | <0.0001 | <0.0001 | 0.0019 | 0.0091 | ||
| Kruskall-Wallis statistic | 35.72 | 35.80 | 27.85 | 23.50 | ||
The parasite lines are each designated with a unique identifier; for example, DT-F1-C1 was selected with DSM255 and TCDC-125334 (DT) came from flask 1 (F1), and is designated as ‘C1’ for ‘Clone 1’. Data is shown as mean EC50 ± standard deviation. Statistical significance was determined by a Kruskal-Wallis test, with post hoc multiple comparisons (Dunn’s) of each clone to 3D7 A10. *p≤0.05; **p≤0.01. Overall statistics are reported for each comparison group. Each dose-response assay was performed with triplicate technical replicates, and average EC50’s were obtained from 3 independent biological replicates. WT = wildtype.
DHODH genotype determined by whole-genome sequencing.
DHODH genotype determined by Sanger sequencing.